• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA Nanotechnology Regulatory Science Program

Description: OCS leadership continues to plan on an annual basis a nanotechnology regulatory science and research agenda to create the tools, methods, and standards to support the responsible development of products that may contain nanomaterials or otherwise involve the application of nanotechnology.

Accomplishment: FDA published the 2013 Nanotechnology Regulatory Science Research Plan, which included FDA’s plan for the NCTR/ORA and White Oak Core Facilities (see content at http://www.fda.gov/ScienceResearch/SpecialTopics/Nanotechnology/ucm273325.htm).

Milestone DescriptionMilestone DateMilestone StatusMilestone Completion Date

A. Hold Center Directors (or their designees) Meeting to obtain review and approval for FDA's FY13 Nanotechnology Regulatory Science Research Program


Completed 8/1/2012

B. Convene FDA Staff Training Sessions



Completed 3/29/2013

C. Award FY13 FDA Nanotechnology CORES (Collaborative Opportunities for Research Excellence in Science) Grants


Completed 3/29/2013

D. Publish FDA's Plan for the NCTR/ORA and White Oak Core Facilities



Completed 9/30/2013

E. Schedule Staff Review of the FY12 FDA Nanotechnology CORES Program Grants


Completed 6/30/2013


  • The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates.

Key Projects Legend

Milestone StatusDefinition
Not Yet StartedWork for specific milestone has not yet been started.
CompletedMilestone and/or overall project is completed.
On TrackMilestone - On track for completion by milestone deadline. Quarter status - Project is on track for completion based on overall milestone status.
On HoldMilestone - On hold, but deadline for completion has not passed. Quarter status - Project is on hold, based on overall milestone status.
DelayedMilestone - Delayed as it has not been completed and deadline has passed. Quarter status - Project is delayed based on overall milestone status.


Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.